MedPath

Validity of Pain Threshold Index in Children

Not Applicable
Conditions
Electroencephalography
Anesthesia, General
Registration Number
NCT03622242
Lead Sponsor
Seoul National University Hospital
Brief Summary

Comparison of total infused dose of remifentanil between pain threshold index monitoring group and control group

Detailed Description

Investigators plan to enroll pediatric patients aged between 3 and 12 years old undergoing surgery under general anesthesia with continuous infusion of 2% propofol and remifentanil.

After dividing them into two groups, investigators monitor pain threshold index and wavelet index in test group and adjust remifentanil infusion to maintain both indices in desirable range, while monitoring only wavelet index and adjust remifentanil infusion to maintain wavelet index and conventional vital signs in desirable range in control group.

Investigators compare consumption of remifentanil, time to extubation after surgery, and post-anesthesia care unit length of stay between both groups.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Children between 3 and 12 years old undergoing orthopedic surgery at extremities under general anesthesia
Exclusion Criteria
  • History of adverse drug reactions to opioids
  • Underlying neurological disease or taking medication for neurologic purpose
  • Patients who were transferred to intensive care unit after the surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Remifentanil consumptionAt the end of anesthesia, total anesthesia time less than 1 day

Total amount of infused remifentanil divided by patient's weight and total anesthesia time

Secondary Outcome Measures
NameTimeMethod
Extubation timeAt the end of anesthesia, less than 1 hour

Elapsed time from end of surgery to extubation

Post-anesthesia care unit length of stayAt discharge from post-anesthesia care unit, less than 1 day

Length of stay at post-anesthesia care unit

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Hee-Soo Kim, MD, Ph.D
Contact
+82-2-2072-3661
dami0605@snu.ac.kr
Sang-Hwan Ji, MD, MS
Contact
+82-2-2072-3661
taepoongshin@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.